SMARCD2 and neuroblastoma: Therefore, we investigated the impact of soluble GD2 (sGD) on the binding of NAXI and DB to GD2 high-expressing neuroblastoma cells CHLA-20 at antibody concentrations ranging from 10−4 to 1 μg/mL in the presence of sGD2 using flow cytometry.